These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 718396)

  • 61. [Estrogens in the woman's life].
    Plotz EJ
    Arch Gynakol; 1971 Jun; 211(1):148-81. PubMed ID: 5108838
    [No Abstract]   [Full Text] [Related]  

  • 62. The effect of oestrogen on plasma levels of luteinizing hormone in euthyroid and thyrotoxic postmenopausal women.
    Akande EO
    J Obstet Gynaecol Br Commonw; 1974 Oct; 81(10):795-803. PubMed ID: 4419555
    [No Abstract]   [Full Text] [Related]  

  • 63. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
    Christiansen C; Riis BJ; Nilas L; Rødbro P; Deftos L
    Lancet; 1985 Oct; 2(8459):800-1. PubMed ID: 2864532
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Aging and calcium metabolism].
    Tomita A; Takatsuki K
    Nihon Naika Gakkai Zasshi; 1985 Oct; 74(10):1366-72. PubMed ID: 4093692
    [No Abstract]   [Full Text] [Related]  

  • 65. [The role of estrogens in bone metabolism in women after menopause].
    Radowicki S; Dowgiałło-Smolarczyk J; Wiśniewska-Sawicka E
    Pol Tyg Lek; 1993 Nov; 48 Suppl 3():10-2. PubMed ID: 8309828
    [TBL] [Abstract][Full Text] [Related]  

  • 66. LOSS OF COMPACT BONE DUE TO MENOPAUSE.
    MEEMA HE; BUNKER ML; MEEMA S
    Obstet Gynecol; 1965 Sep; 26():333-43. PubMed ID: 14341197
    [No Abstract]   [Full Text] [Related]  

  • 67. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT).
    Hadji P; Gottschalk M; Ziller V; Kalder M; Jackisch C; Wagner U
    Maturitas; 2007 Mar; 56(3):312-21. PubMed ID: 17049767
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Preliminary study of the influence of the oral synthetic oestrogen-gestogens on the rate of calcium, magnesium and silicon in some tissues fo the female rats].
    Charnot Y; Gozan KB; Peres G
    Ann Endocrinol (Paris); 1974; 35(3 bis):329-35. PubMed ID: 4464800
    [No Abstract]   [Full Text] [Related]  

  • 69. Influence of calcium depletion on medullary bone of laying hens.
    de Bernard B; Stagni N; Camerotto R; Vittur F; Zanetti M; Zambonin Zallone A; Teti A
    Calcif Tissue Int; 1980; 32(3):221-8. PubMed ID: 6775791
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Estrogens and postmenopausal osteoporosis].
    Linde J; Friis T; Ostergaard E
    Ugeskr Laeger; 1977 Jun; 139(26):1536-41. PubMed ID: 560074
    [No Abstract]   [Full Text] [Related]  

  • 71. The effect of oestrogen implants on high density lipoproteins and its subfractions in women in their pre-mature menopause.
    Brook JG; Aviram M; Oettinger M; Sharf M
    Maturitas; 1982 Dec; 4(4):257-65. PubMed ID: 7169961
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A new tracer method for the calculation of rates of bone formation and breakdown in osteoporosis and other generalised skeletal disorders.
    Reeve J; Hesp R; Wootton R
    Calcif Tissue Res; 1976 Dec; 22(2):191-206. PubMed ID: 1000353
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Osteoporosis, oestrogens and oöphorectomy. A proposed new test of oestrogenic potency.
    Utian WH
    S Afr Med J; 1975 Mar; 49(12):433-6. PubMed ID: 168644
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
    Kanis JA; Johnell O; Gullberg B; Allander E; Dilşen G; Gennari C; Lopes Vaz AA; Lyritis GP; Mazzuoli G; Miravet L
    BMJ; 1992 Nov; 305(6862):1124-8. PubMed ID: 1463947
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Skeletal effects of selective oestrogen receptor modulators (SERMs).
    Díez JL
    Hum Reprod Update; 2000; 6(3):255-8. PubMed ID: 10874570
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Substitution estrogen therapy in the prevention of postmenopausal osteoporosis and cardiovascular diseases. Results of long-term therapy].
    Ciammella M; Guareschi B; Pes S; Cocucci C; Nencioni T
    Minerva Ginecol; 1993; 45(1-2):53-5. PubMed ID: 8385750
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relation to osteoporosis of age- and hormone-induced changes in the metabolism of collagen and bone.
    Laitinen O
    Isr J Med Sci; 1976 Jul; 12(7):620-37. PubMed ID: 972017
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence on blood pressure of oestrogen substitution therapy in the menopause.
    Eggertsen R
    Scand J Prim Health Care; 1987 Feb; 5(1):51-3. PubMed ID: 3035679
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Changes in bone mineral content and bone metabolism related to menopause].
    Ohta H; Nemoto K; Nozawa S; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1447-54. PubMed ID: 2584821
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Sex hormones and calcitonin secretion].
    Klotz HP; Delorme ML; Ochoa F; Aussenard C
    Sem Hop; 1975 Apr; 51(20):1333-6. PubMed ID: 175475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.